News Breaks |
|
|
| September 6, 2012 |
| 09:32 EDT |  | SHPG | Shire settles all pending litigation with Anchen, TWi
Shire said it has settled all pending litigation with Anchen Pharmaceuticals and TWi Pharmaceuticals in connection with TWi's Abbreviated New Drug Application for a generic version of Shire's INTUNIV for the treatment of Attention Deficit Hyperactivity Disorder. Anchen is TWi's authorized distributor and its filing agent with the FDA. The settlement provides TWi with a license to make, and Anchen a license to market, TWi's generic versions of INTUNIV in the United States on July 1, 2016, or earlier in certain limited circumstances. Such sales will require the payment of a royalty to Shire, except in certain circumstances. |
|
|
News For SHPG From The Last 14 Days Check below for free stories on SHPG the last two weeks. |
|
|
| May 20, 2013 |
| 10:03 EDT | | SHPG | Shire advances after report renews takeover speculation
 Subscribe for More Information |
|
| 07:27 EDT |  | SHPG | American Psychiatric Association to host annual meeting
Subscribe for More Information |
|
| 07:01 EDT | | SHPG | Sangamo BioSciences announces positive data for Vivo Protein platform
Sangamo BioSciences (SGMO) announced the presentation of new data demonstrating the successful application of Sangamo's proprietary In Vivo Protein Replacement Platform to produce therapeutically relevant levels of Factor VIII in a mouse model. Sangamo has partnered with Shire (SHPG) to develop ZFP Therapeutics for both hemophilia A and B using this approach. |
|
| 06:30 EDT |  | SHPG | Leerink estimates Shire takeout value at least $110 per share
Leerink says a takeover price for Shire (SHPG) would need to be at least $110 per share in order to get the company's board to consider a sale. The firm notes a Daily Mail report last night said Bristol-Myers (BMY) has engaged advisors to study an acquisition of Shire and that Shire's CEO has contacted bankers to consider anti-takeover measures. Leerink believes a Bristol-Myers takeover of Shire would make sense and keeps an Outperform rating on Shire. |
|
| 06:25 EDT |  | SHPG | Shire may return cash to thwart takeover, Daily Mail reports
Subscribe for More Information |
|
| May 14, 2013 |
| 07:24 EDT | | SHPG | EBD Group to host a conference
BioTrinity 2013 is being held in Newbury, England on May 14-16. |
|
| May 10, 2013 |
| 10:00 EDT |  | SHPG | On The Fly: Analyst Downgrade Summary
Subscribe for More Information |
|
| 05:42 EDT | | SHPG | Shire downgraded to Neutral from Overweight at JPMorgan
|
|
|
|
|
|
